Rankings
▼
Calendar
FBLG (FibroBiologics, Inc. Common Stock) Stock Financials & Earnings | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
Mkt Cap
$17M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$19M
EPS (TTM)
-$0.44
Free Cash Flow (TTM)
-$17M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$2M
Q2 23
$0
$0
-$2M
Q3 23
$0
$0
-$2M
Q4 23
$0
$0
-$2M
Q1 24
$0
$0
-$3M
Q2 24
$0
$0
-$3M
Q3 24
$0
$0
-$3M
Q4 24
$0
$0
-$4M
Q1 25
$0
$0
-$5M
Q2 25
$0
$0
-$4M
Q3 25
$0
-$231K
-$5M
Q4 25
$0
-$234K
-$3M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$2M
-$2M
Q2 23
-$2M
-$2M
Q3 23
-$1M
-$2M
Q4 23
-$2M
-$2M
Q1 24
-$4M
-$4M
Q2 24
-$2M
-$2M
Q3 24
-$3M
-$3M
Q4 24
-$3M
-$3M
Q1 25
-$5M
-$5M
Q2 25
-$4M
-$4M
Q3 25
-$4M
-$4M
Q4 25
-$3M
-$3M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$56K
Q2 23
$24K
Q3 23
$413K
Q4 23
$2K
Q1 24
$8K
Q2 24
$66K
Q3 24
$11K
Q4 24
$99K
Q1 25
$43K
Q2 25
$213K
Q3 25
$6K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+148.6%
Q2 23
—
+129.7%
Q3 23
—
+53.0%
Q4 23
—
+90.2%
Q1 24
—
+52.3%
Q2 24
—
+54.0%
Q3 24
—
+63.4%
Q4 24
—
+49.7%
Q1 25
—
+31.3%
Q2 25
—
+39.3%
Q3 25
—
+50.3%
Q4 25
—
-30.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$448K
—
Q2 23
$448K
—
Q3 23
$437K
—
Q4 23
$432K
—
Q1 24
$525K
—
Q2 24
$578K
—
Q3 24
$571K
—
Q4 24
$544K
—
Q1 25
$551K
—
Q2 25
$729K
—
Q3 25
$704K
—
Q4 25
$702K
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$478K
$2M
—
Q2 23
$547K
$2M
—
Q3 23
$571K
$1M
—
Q4 23
$773K
$2M
—
Q1 24
$960K
$2M
—
Q2 24
$975K
$2M
—
Q3 24
$1M
$2M
—
Q4 24
$1M
$2M
—
Q1 25
$2M
$3M
—
Q2 25
$2M
$2M
—
Q3 25
$3M
—
$2M
Q4 25
$797K
$4M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$0
$0
$0
Q2 23
$11M
$0
$11M
Q3 23
$11M
$0
$11M
Q4 23
$9M
$0
$9M
Q1 24
$8M
$0
$8M
Q2 24
$6M
$0
$6M
Q3 24
$8M
$0
$8M
Q4 24
$14M
$0
$14M
Q1 25
$9M
$0
$9M
Q2 25
$9M
$0
$9M
Q3 25
$5M
$0
$5M
Q4 25
$5M
$0
$5M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
32M
+7.0%
Q2 23
32M
+0.0%
Q3 23
32M
+0.0%
Q4 23
32M
-2.0%
Q1 24
31M
-2.1%
Q2 24
33M
+5.1%
Q3 24
34M
+2.4%
Q4 24
35M
+3.8%
Q1 25
37M
+5.5%
Q2 25
39M
+5.4%
Q3 25
43M
+11.5%
Q4 25
45M
+3.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
—
—
FY 24
$0
13
FY 25
$0
15
marketcaparena.com